The Social Chain AG

  • WKN: A1YC99
  • ISIN: DE000A1YC996
  • Land: Deutschland

Nachricht vom 30.12.2019 | 21:30

The Social Chain AG: The Social Chain AG increases its current stake in SOLIDMIND Nutrition GmbH into a majority stake and furthermore acquires all shares in CONTEAM : BELOW GmbH

The Social Chain AG / Key word(s): Takeover/Capital Increase
The Social Chain AG: The Social Chain AG increases its current stake in SOLIDMIND Nutrition GmbH into a majority stake and furthermore acquires all shares in CONTEAM : BELOW GmbH

30-Dec-2019 / 21:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication Pursuant to Article 17 MAR

The Social Chain AG increases its current stake in SOLIDMIND Nutrition GmbH into a majority stake under issuance of new shares by way of capital increase in kind and payment of a cash purchase price and furthermore acquires all shares in CONTEAM : BELOW GmbH

Berlin, December 30, 2019 - With the approval of the Supervisory Board, the Management Board of The Social Chain AG (WKN: A1YC99, ISIN: DE000A1YC996, ticker: PU11) (the "Company") has resolved today to increase the Company's share capital with exclusion of shareholders' subscription rights. The capital increase shall be effected against contribution in kind with partial utilization of the existing authorized capital pursuant to Section 3 (6) of the Articles of Association of the Company. The Company's share capital will be increased from EUR 10,114,118.00 by EUR 75,600.00 to EUR 10,189,718.00 through the issue of 75,600 new no-par- value registered shares with a notional value in the share capital of EUR 1.00 per share.

Only the shareholder of SOLIDMIND Nutrition GmbH, Mr. Lars Müller, is authorized to subscribe for the 76,500 new shares to be issued. In return, he will contribute approx. 19% of the entire share capital in SOLIDMIND Nutrition GmbH into the Company on the basis of a contribution agreement already concluded within the scope of the aforementioned capital increase through contribution in kind. The total of 75,600 new shares will be issued at an issue price of EUR 20.00 per share.

The Company acquires further 3.1% of the share capital of SOLIDMIND Nutrition GmbH against payment of a fixed cash purchase price in a low six-digit amount and will control the majority of the share capital of SOLIDMIND Nutrition GmbH subsequently after the capital increase in kind has been successfully registered in the commercial register.

Furthermore, the Company - represented by its supervisory board - has acquired the entire share capital of CONTEAM : BELOW GmbH with registered seat in Mainz by way of a notarized purchase agreement as of today against payment of a fixed cash purchase price in a low million Euro range.

 

About THE SOCIAL CHAIN AG

As the first integrated social media company, THE SOCIAL CHAIN AG combines social media and social commerce, integrated through its own tech platform LINKS. The company is a pioneer in the creation, development and scaling of social media brands. The company's headquarters are in Berlin with additional offices in Manchester, London, New York and Munich.

 

Contact:
Jana Walker | Investor Relations
ir@socialchain.com


30-Dec-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

MBH Corporation. Hohes Kurspotenzial

Die MBH Corporation plc hat in den vergangenen Berichtsperioden eine sehr hohe M&A-Aktivität aufgezeigt. Unter Anwendung der so genannten Agglomeration Methodology hat die Beteiligungsgesellschaft branchenübergreifend seit 2018 11 Beteiligungen erworben. Bei einem Pro-Forma-Umsatz der Beteiligungsgesellschaften von über 120 Mio. GBP und einem Pro-Forma-EBITDA in Höhe von über 11 Mio. GBP weist die MBH derzeit eine Marktkapitalisierung von umgerechnet gerade einmal 19,8 Mio. GBP auf. Ausgehend vom aktuellen Aktienkurs liegt zu unserem Kursziel in Höhe von 1,95 € ein hohes Kurspotenzial vor

News im Fokus

Fresenius Medical Care kooperiert mit anderen Dialyseanbietern zur Bekämpfung der Coronavirus-Pandemie in den USA

01. April 2020, 09:01

Aktueller Webcast

SeaChange Corporation

Fourth Quarter Fiscal Year 2020 Results

06. April 2020

Aktuelle Research-Studie

Original-Research: Valneva SA (von First Berlin Equity Research GmbH): Kaufen Valneva SA

02. April 2020